Technical Analysis: Based on the latest price data, CVS is currently trading at $52.65, showing a positive momentum with a 1.27% gain in the last trading session . The RSI(14) at 62.84 indicates the stock is approaching but not yet in overbought territory.
The Fibonacci levels suggest:
News Impact: Recent news has mixed implications for CVS:
Price Prediction for Next Week: Based on technical indicators and news sentiment:
Trading Recommendation: BUY with the following parameters:
The recommendation is based on:
The price of CVS is predicted to go up -13.56%, based on the high correlation periods with TTI. The similarity of these two price pattern on the periods is 97.66%.
CVS
TTI
Year
CVS Price Forecast($)
Potential Return(%)
2025
55.000
14.510
2026
60.000
24.920
2027
65.000
35.330
2028
65.000
35.330
2029
65.000
35.330
2030
65.000
35.330
CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the organization.
The firm's entry into provider services has the potential to improve returns for all of CVS' segments if it can help patients more easily and cost-effectively manage chronic conditions through early intervention.
CVS' PBM remains an industry leader due to its intense focus on pharmaceutical cost trends that should continue to attract clients.
Truist Securities
Price Target
$67 → $60
Upside
+30.95%
Deutsche Bank
Price Target
$66
Upside
+11.51%
TD Cowen
Price Target
$73 → $80
Upside
+33.11%